Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$12,361,989
+$456,050 QoQ
Shares Held
48,675
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#984
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. JNJ ranks #5 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,361,989 | 48,675 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $11,905,939 | 48,707 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $10,206,360 | 49,318 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $9,574,903 | 51,639 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $7,961,330 | 52,120 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $9,007,599 | 54,315 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $8,181,008 | 56,569 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $9,138,563 | 56,390 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $8,371,167 | 57,274 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $8,839,499 | 55,879 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $8,599,069 | 54,862 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $8,245,093 | 52,938 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $10,261,743 | 61,997 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $9,561,795 | 61,689 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $10,583,808 | 59,914 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $9,455,766 | 57,883 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $10,407,056 | 58,628 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $10,907,974 | 61,547 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $10,701,454 | 62,556 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $9,475,528 | 58,672 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $9,645,032 | 58,547 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $9,888,282 | 60,166 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $9,379,061 | 59,595 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $9,090,315 | 61,058 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $8,629,900 | 61,366 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $8,144,877 | 62,113 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||